Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Recommendations on whether to screen for NAFLD in diabetic patients remains conflicted be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diagnostics (Basel)
Autores principales: Tuong, Tran Thi Khanh, Tran, Dang Khoa, Phu, Pham Quang Thien, Hong, Tong Nguyen Diem, Chu Dinh, Thien, Chu, Dinh Toi
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151057/
https://ncbi.nlm.nih.gov/pubmed/32183383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10030159
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares